LivaNova PLC is a global medical technology company dedicated to developing, manufacturing, and marketing a variety of therapeutic solutions. The company operates through three key segments.
Livanova stock last closed at $82.20, up 1.76% from the previous day, and has increased 54.92% in one year. It has overperformed other stocks in the Medical Devices industry by 1.54 percentage points. Livanova stock is currently +68.37% from its 52-week low of $48.82, and -4.15% from its 52-week high of $85.76.
At the moment, there are 55.09M shares of LIVN outstanding. The market capitalization of LIVN is $4.53B. In the last 24 hours, 592,000 LIVN shares were traded.
How to Buy Livanova Stock
Wondering how to invest in Livanova stock? Here's how.
Choose where to buy Livanova stock: You need to pick an online brokerage, but don't worry - we've sifted through dozens of stock brokerages and apps to help you determine where to buy Livanova stock.
Open a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
Deposit funds into your brokerage account: Choose your payment method and add your information.
Evaluate Livanova stock: The Livanova ticker symbol is LIVN. Is Livanova stock a good investment? Should you buy shares of LIVN? How do LIVN's underlying business fundamentals look? Do top analysts think Livanova is a good buy? Why has LIVN's stock price moved recently? (Hint: Our stock market research tools can help you understand if LIVN is a good stock to buy).
Make your LIVN trade: Decide if you will purchase LIVN shares at the current market price or use a limit order to purchase LIVN stock at a particular price.
Get key alerts regarding your LIVN investment: Create a watchlist to monitor your position in Livanova shares.
Step 1: Choose where to buy Livanova stock
You will need a brokerage account in order to access the NASDAQ market and buy LIVN stock.
A brokerage account is an investment account that enables you to buy and sell a number of financial instruments, such as stocks, bonds, mutual funds, and ETFs.
Our favorite brokerage: eToro
Based on our research, eToro is the best place to buy stocks. eToro gives you:
You can invest in stocks with 0% commissions: Invest without commissions.
Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
Access to world financial markets: From Tech to Real Estate, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top stock exchanges.
Social investing: eToro offers a community with more than 20 million users globally. Talk to, learn from, and copy the crypto trades of top investors.
Security: eToro is a regulated and licensed fintech leader.
Buy other assets: Such as ETFs and cryptos.
Get $10 towards your purchase of shares by opening an account with eToro today. This offer is only for US users.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Open a brokerage account
Now that you've selected the right brokerage, the next step is to fill out some personal details so you can invest in LIVN stock today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Evaluate Livanova stock
After you have identified the best place to buy Livanova stock, it's crucial to analyze their stock before you buy, so you truly wrap your head around the risk and upside.
Livanova Numbers
LIVN Price
$82.20
1w %
8.47%
1y %
54.92%
5y %
6.84%
P/E
23.9x
P/B
3.42x
P/S
3.07x
PEG
1.61x
Revenue
$1.47B
Earnings
$188.55M
Fore. Rev. Growth
5.93%
Fore. Earn. Growth
14.81%
Market Cap
$4.53B
Next Earnings
N/A
Next Dividend
N/A
Livanova Overview
WallStreetZen was built to help average investors perform more in-depth fundamental analysis.
LIVN's operating cash flow of $249.26M allows it to safely service it's debt of $343.16M.
There are more short-term assets than long-term liabilities on the LIVN balance sheet.
There are more short-term assets than short-term liabilities on the LIVN balance sheet.
LIVN profit margin has gone up from -16.1% to 12.8% in the past year.
Total LIVN debt is lower than 5 years ago, relative to shareholder equity.
Signs that LIVN is not financially healthy:
LIVN earnings of $143.71M is not sufficient to cover its interest payments.
LIVN has a relatively high debt to equity ratio of 0.99.
Is Livanova stock a Buy, Hold, or Sell, according to Wall Street analysts?
Out of 6 Wall Street analysts who give ratings on LIVN, the consensus analyst rating on Livanova is a Buy
Please keep in mind that analyst forecasts are not stock recommendations, nor are they investment advice.
Most Recent LIVN Analyst Upgrades/Downgrades
David Rescott, a top 18% analyst from Baird maintains LIVN with a buy rating and lowers their LIVN price target from $78.00 to $76.00, on May 7, 2026.
Baird's David Rescott lowered their price target on Livanova (NASDAQ: LIVN) by 2.6% from $78 to $76 on 2026/05/07. The analyst maintained their Buy rating on the stock.
LivaNova reported its Q1 2026 earnings.
With the company's broad portfolio strength and tailwinds emerging, Rescott said they revised their model in response to the quarter's beat-and-raise results.
Earnings Report
For Q1 2026, LivaNova reported:
EPS of $0.98, which beat the Zacks Consensus Estimate of $0.85 and, by 11,4%, Q1 2025’s $0.88.
Revenue of $362.3M, which beat the Zacks Consensus Estimate by 3.60% and, by 14.3%, Q1 2025’s $316.9M.
For FY 2026, management guided:
EPS of $4.20 to $4.30.
Revenue growth of 7.0% to 8.0%.
CEO Vladimir Makatsaria commented: “In Q1, LivaNova delivered double‑digit revenue growth with strength across all regions, driven by sustained performance in our Cardiopulmonary and Epilepsy businesses.
“We also made meaningful progress in Obstructive Sleep Apnea, accomplishing key regulatory and clinical milestones.
“These achievements support a solid foundation for entry into the high‑growth, high‑margin OSA market with a differentiated technology.
“Our updated 2026 guidance reflects strong execution in the core businesses alongside continued investment to unlock this next phase of growth and value creation.
“We remain focused on disciplined execution as we advance our long‑term strategy, consistent with what we outlined at our 2025/11 Investor Day.”
Last year, LIVN revenue was $1.47B. Over the past five year, LIVN's revenue has gone up by 7.57% per year. This was slower than the Medical Devices industry average of 8.87%.
No, Livanova doesn't provide an income stream by paying out dividends.
What do other traders have to say about LIVN?
One of the major reasons eToro is our favorite brokerage is because of its social trading community.
Click below to find out what other community members have to say.
Step 5: Make your LIVN trade
There are two primary order types:
Market order: A market order is an order to buy or sell a stock at the best available price. Market orders are mostly sufficient.
Limit order: A limit order is an order to buy or sell a stock at a specific price (or better). If you want to make sure you're buying or selling at a given price, use a limit order.
Click the Open Trade button and eToro will execute your order.
If you need more info about buying stocks on eToro, click the how to video below:
As of Aug 13, 2026, it costs $82.20 to buy one share of Livanova stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $10, you can buy 0.122 shares of LIVN.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.